Author Contributions: Drs Malani and Singal had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Malani, Vandenberg, Singal, Kasotakis, Kaakaji.
Acquisition of data: Malani, Vandenberg, Singal, Kasotakis, Moudgal, Jagarlamudi, Neelakanta, Kaakaji.
Analysis and interpretation of data: Malani, Vandenberg, Singal, Kasotakis, Koch, Halasyamani, Kaakaji, Kauffman.
Drafting of the manuscript: Malani, Vandenberg, Singal, Kasotakis, Koch, Kaakaji, Kauffman.
Critical revision of the manuscript for important intellectual content: Malani, Vandenberg, Singal, Kasotakis, Koch, Moudgal, Jagarlamudi, Neelakanta, Otto, Halasyamani, Kauffman.
Statistical analysis: Malani, Singal.
Administrative, technical, or material support: Malani, Kasotakis, Koch, Moudgal, Jagarlamudi, Neelakanta, Halasyamani, Kaakaji.
Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Malani reported receiving payment for speaker's bureaus from Cubist Pharmaceuticals; and being a shareholder in Pfizer Pharmaceuticals. Dr Moudgal reported serving on advisory boards for Gilead and Merck; and receiving payment for speaker's bureaus from Pfizer, Genentech, and Cubist Pharmaceuticals. Dr Kauffman reported serving as the chair of a data and safety monitoring committee for the Merck/Mycoses Study Group; and serving on an adjudication panel for New England Research Institute. No other authors reported any disclosures.
Online-Only Material: The Author Video Interview is available .